Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Characterization of the Effects of Oral NAD+ in a Wellness Cohort

NCT07336836 is registered in ClinicalTrials.gov with BioNADrx Holdings, Inc. Bryleos as lead sponsor.

NCT NCT07336836
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07336836 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Characterization of the Effects of Oral NAD+ in a Wellness Cohort
Lead sponsor
BioNADrx Holdings, Inc. Bryleos
Phase
Phase 1
Overall status
Completed
Start date
February 23, 2022
Completion date
June 4, 2022
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

health adult subjects, healthy participants